awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53705974-1A7330D4-9E2B-45FB-819B-63BC9494FFB0
Q53705974-1A7330D4-9E2B-45FB-819B-63BC9494FFB0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53705974-1A7330D4-9E2B-45FB-819B-63BC9494FFB0
BRAF and MEK Inhibitors: Use and Resistance in BRAF-Mutated Cancers.
P2860
Q53705974-1A7330D4-9E2B-45FB-819B-63BC9494FFB0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53705974-1A7330D4-9E2B-45FB-819B-63BC9494FFB0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2d968b7c83b96f353d44942ad3b37b9a9a427b64
P2860
Combination of vemurafenib and cobimetinib in patients with advanced BRAF(V600)-mutated melanoma: a phase 1b study.